Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ang, Zhiwei ^a   Er, Jun Zhi ^a   Tan, Nguan Soon ^b,c   Lu, Jinhua ^d   Liou, Yih Cherng ^a   Grosse, Johannes ^e   Ding, Jeak Ling ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e Takeda Cambridge Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988923392     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34145     Document Type: Article

References (68)

1. Guarner, F. & Malagelada, J.-R. Gut flora in health and disease. Lancet 361, 512-519 (2003).
2. Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A. & Jenkins, D. J. A. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235-243 (2006).
3. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. & Macfarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221-1227 (1987).
4. Brown, A. J., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312-11319 (2003).
5. Le Poul, E., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 25481-25489 (2003).
6. Nilsson, N. E., Kotarsky, K., Owman, C. & Olde, B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun. 303, 1047-1052 (2003).
7. Maslowski, K. M., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286 (2009).
8. Sina, C., et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. Baltim. Md 1950 183, 7514-7522 (2009).
9. Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M. & Kim, C. H. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145, 396-406-10 (2013).
10. Smith, P. M., et al. The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis. Science 341, 569-573 (2013).
11. Masui, R., et al. G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm. Bowel Dis. 19, 2848-2856 (2013).
12. Bjursell, M., et al. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 300, E211-E220 (2011).
13. Tolhurst, G., et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364-371 (2012).
14. Kimura, I., et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
15. Trompette, A., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159-166 (2014).
16. Ang, Z. & Ding, J. L. GPR41 and GPR43 in Obesity and Inflammation-Protective or Causative? Front. Immunol. 7, 28 (2016).
17. Grimm, M. C., et al. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastroenterol. Hepatol. 10, 387-395 (1995).
18. Nakanishi, Y., Sato, T. & Ohteki, T. Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization. Mucosal Immunol. doi: 10.1038/mi.2014.53 (2014).
19. Bain, C. C., et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 6, 498-510 (2013).
20. Kawanaka, N., et al. CD14+ ,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46, 2578-2586 (2002).
21. Koch, S., Kucharzik, T., Heidemann, J., Nusrat, A. & Luegering, A. Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease. Clin. Exp. Immunol. 161, 332-341 (2010).
22. Seok, J., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110, 3507-3512 (2013).
23. Hong, Y.-H., et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146, 5092-5099 (2005).
24. Dewulf, E. M., et al. Evaluation of the relationship between GPR43 and adiposity in human. Nutr. Metab. 10, 11 (2013).
25. Priyadarshini, M., et al. An acetate-specific GPCR, FFAR2, regulates insulin secretion. Mol. Endocrinol. Baltim. Md me20151007, doi: 10.1210/me.2015-1007 (2015).
26. Namour, F., et al. Safety, Pharmacokinetics and Pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. Br. J. Clin. Pharmacol. doi: 10.1111/bcp.12900 (2016).
27. Karaki, S.-I., et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J. Mol. Histol. 39, 135-142 (2008).
28. Swirski, F. K., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616 (2009).
29. Ang, Z., Er, J. Z. & Ding, J. L. The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes. Sci. Rep. 5, (2015).
30. Senga, T., et al. LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. Blood 101, 1185-1187 (2003).
31. Cox, M. A., et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J. Gastroenterol. WJG 15, 5549-5557 (2009).
32. Bloemen, J. G., et al. Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin. Nutr. Edinb. Scotl. 28, 657-661 (2009).
33. Leonard, J. N., Chu, Z. L., Bruce, M. A. & Boatman, P. D. Gpr41 and modulators thereof for the treatment of insulin-related disorders. (2006).
34. Wang, Y., et al. The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. Bioorg. Med. Chem. Lett. 20, 493-498 (2010).
35. Ii, M., et al. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol. 69, 1288-1295 (2006).
36. Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y. & Kimura, H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur. J. Pharmacol. 584, 40-48 (2008).
37. Weichhart, T. & Saemann, M. D. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann. Rheum. Dis. 67 Suppl 3, iii70-iii74 (2008).
38. Arthur, J. S. C. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679-692 (2013).
39. Takasaki, J., et al. A novel Galphaq/11-selective inhibitor. J. Biol. Chem. 279, 47438-47445 (2004).
40. Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
41. Ingersoll, M. A., et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115, e10-e19 (2010).
42. Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wildtype receptors. Naunyn. Schmiedebergs Arch. Pharmacol. 366, 381-416 (2002).
43. Hudson, B. D., et al. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 26, 4951-4965 (2012).
44. Lee, S. U., et al. β-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-β B. Biol. Pharm. Bull. 36, 1754-1759 (2013).
45. Ozes, O. N., et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85 (1999).
46. Fraser, C. C. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer. Int. Rev. Immunol. 27, 320-350 (2008).
47. Peters, M. F. & Scott, C. W. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J. Biomol. Screen. 14, 246-255 (2009).
48. Vooijs, M. & Berns, A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293-5303 (1999).
49. Oh, S. Y., Cho, K.-A., Kang, J. L., Kim, K. H. & Woo, S.-Y. Comparison of experimental mouse models of inflammatory bowel disease. Int. J. Mol. Med. 33, 333-340 (2014).
50. Gibbons, D. L. & Spencer, J. Mouse and human intestinal immunity: same ballpark, different players; different rules, same score. Mucosal Immunol. 4, 148-157 (2011).
51. Jostins, L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
52. Neurath, M. F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14, 329-342 (2014).
53. Yonezawa, T., Kobayashi, Y. & Obara, Y. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell. Signal. 19, 185-193 (2007).
54. Vinolo, M. A. R., et al. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PloS One 6, e21205 (2011).
55. Taboubi, S., et al. Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathwaydependent keratinocyte migration. Mol. Biol. Cell 21, 946-955 (2010).
56. Singh, N., et al. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J. Biol. Chem. 285, 27601-27608 (2010).
57. Thangaraju, M., et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69, 2826-2832 (2009).
58. Ritter, S. L. & Hall, R. A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat. Rev. Mol. Cell Biol. 10, 819-830 (2009).
59. Tang, C., et al. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat. Med. 21, 173-177 (2015).
60. Gordon, S. & Taylor, P. R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964 (2005).
61. Ginhoux, F. & Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392-404 (2014).
62. Linton, L., et al. HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD. Clin. Transl. Gastroenterol. 3, e29 (2012).
63. Ulven, T. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets. Front. Endocrinol. 3, 111 (2012).
64. Chen, Q., et al. Human natural killer cells control Plasmodium falciparum infection by eliminating infected red blood cells. Proc. Natl. Acad. Sci. USA. 111, 1479-1484 (2014).
65. Yang, J., Zhang, L., Yu, C., Yang, X.-F. & Wang, H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 2, 1 (2014).
66. Pavlidis, P. & Noble, W. S. Matrix2png: a utility for visualizing matrix data. Bioinforma. Oxf. Engl. 19, 295-296 (2003).
67. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45-e45 (2001).
68. Pfaffl, M. W., Horgan, G. W. & Dempfle, L. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36-e36 (2002).